SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: smh who wrote (5300)1/2/2002 5:28:58 PM
From: Biomaven  Read Replies (2) | Respond to of 52153
 
The US Supreme Court on January 8th will be hearing the Festo patent case. If they don't overrule the Court of Appeals, there might be a significant impact on existing biotech patents and hence biotech valuations. (One of the dissenting Court of Appeals judges specifically cited biotech as an example where the doctrine of equivalents is vital to the patent holder).

This site provides all the briefs and some associated commentary:

supreme.usatoday.findlaw.com

Peter